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Supporting information Figure S1: Diversity of nonulosonic acids biosynthesized by bacteria. 
Many bacterial species have been shown to produce N-acetylneuraminic acid (Sialic acid) or the 
di-N-acetylated bacterial specific NulOs of which there are seven described isomers. 
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 Supporting information Figure S2: Nuclear Magnetic Resonance (NMR) Characterization 
Spectra of Leg5Ac7AcAla.  (A). Proton 1HNMR analysis in D2O (water suppression bbfo_zgpr at 
4.70ppm) with zoomed in field offset in left corner (1-4.5ppm). (B) Carbon 13CNMR analysis in 
D2O. (C) 2-D Correlation Spectroscopy (COSY) and (D) 2-D Heteronuclear Single Quantum 
Correlation (HSQC) NMR spectra without water suppression. 
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Supporting information Figure S3: Mass spectrometry analysis of V. vulnificus YJ016 nab1 
nonulosonic acid.  A) DMB-derivatized NulO collected from YJ016 nab1 which B) has a [M+H]+ 
of 451.20.  
  
  
 
Supporting information Figure S4: Predicted catabolism of Leg5Ac7AcAla in V. vulnificus 
CMCP6. A) Genomic arrangement of sialic acid transport and catabolism cluster in V. vulnificus 
and B) schematic diagram of the predicted accumulation of Leg5Ac7AcAla upon mutation of 
nanA/nab1 mutant. C) HPLC analysis of DMB-derivatized cellular fractions from CMCP6 
nanA revealing accumulation of sialic acid from the media as well as WT levels of 
Leg5Ac7AcAla. 
 
 Supporting information Figure S5: NulO mutant exhibit increased sensitivity towards the 
antimicrobial peptide polymyxin B (PmB). Wild-type CMCP6 and the nab2 deletion mutant 
were grown to mid-exponential phase and resuspended in PBS containing 80 g/ml of PmB. 
Cell lysis was monitored as a decreased in optical density measured every 5 minutes over the 
course of 60 minutes. Error bars represent standard deviation (SD). Experiments performed in 
triplicate and two biological replicates. 
 
 
Supporting information Figure S6: V. vulnificus survival in human serum. A) WT CMCP6 the 
nab2 deletion mutant and a capsule negative strain CMCP6/T were exposed to active normal 
human serum or B) heat inactivated serum. The CFUs were enumerated immediately following 
exposure to serum and in 30 min. intervals for 2 h. Experiment was conducted in duplicate with 
three technical replicates. Error bars represent SD. 
  
 
Supporting information Figure S7: Biofilm formation V. vulnificus nab1 complement strain. 
The strains were grown statically for 24 h in Marine Broth at RT. Biofilms were stained with 0.1% 
crystal violet resuspended in DMSO and the OD measured. Individual points represent 
independent experiments consisting of six technical replicates. Lines indicate mean and +/- SD. 
 
